HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The efficacy of oral azithromycin in clearing ocular chlamydia: mathematical modeling from a community-randomized trachoma trial.

Abstract
Mass oral azithromycin distributions have dramatically reduced the prevalence of the ocular strains of chlamydia that cause trachoma. Assessing efficacy of the antibiotic in an individual is important in planning trachoma elimination. However, the efficacy is difficult to estimate, because post-treatment laboratory testing may be complicated by nonviable organisms or reinfection. Here, we monitored ocular chlamydial infection twice a year in pre-school children in 32 communities as part of a cluster-randomized clinical trial in Tanzania (prevalence in children was lowered from 22.0% to 4.7% after 3-year of annual treatment). We used a mathematical transmission model to estimate the prevalence of infection immediately after treatment, and found the effective field efficacy of antibiotic in an individual to be 67.6% (95% CI: 56.5-75.1%) in this setting. Sensitivity analyses suggested that these results were not dependent on specific assumptions about the duration of infection. We found no evidence of decreased efficacy during the course of the trial. We estimated an 89% chance of elimination after 10 years of annual treatment with 95% coverage.
AuthorsFengchen Liu, Travis C Porco, Harran A Mkocha, Beatriz Muñoz, Kathryn J Ray, Robin L Bailey, Thomas M Lietman, Sheila K West
JournalEpidemics (Epidemics) Vol. 6 Pg. 10-7 (Mar 2014) ISSN: 1878-0067 [Electronic] Netherlands
PMID24593917 (Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 The Authors. Published by Elsevier B.V. All rights reserved.
Chemical References
  • Anti-Bacterial Agents
  • Azithromycin
Topics
  • Administration, Oral
  • Anti-Bacterial Agents (administration & dosage, therapeutic use)
  • Azithromycin (administration & dosage, therapeutic use)
  • Child, Preschool
  • Cluster Analysis
  • Female
  • Follow-Up Studies
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Mathematical Computing
  • Models, Theoretical
  • Prevalence
  • Research Design
  • Tanzania (epidemiology)
  • Trachoma (drug therapy, epidemiology, transmission)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: